ClinicalTrials.govpublic full text
Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants
kidney transplant rejection, kidney transplant, cellular therapy, anti-rejection therapy, living donor, hla-matched, hematopoietic stem cells (hsc), cd34+, cd3+, t cells, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830367
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.